Pancrelipase
Mechanism of effect
Pharmacodynamic
Pharmacokinetics
Drug indications
Dosage
Maintenance dose: Up to 2500 lipase units/kg orally per meal
Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat
ingested per day
Usual Adult Dose for Cystic Fibrosis
Initial dose: 500 lipase units/kg orally per meal
Maintenance dose: Up to 2500 lipase units/kg orally per meal
Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat ingested per day
sual Adult Dose for Chronic Pancreatitis
Initial dose: 500 lipase units/kg orally per meal
Maintenance dose: Up to 2500 lipase units/kg orally per meal
Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat ingested per day
Usual Pediatric Dose for Pancreatic Exocrine Dysfunction
Up to 12 months: 2000 to 4000 lipase units per 120 mL of formula or breastfeeding
Older than 12 months to younger than 4 years:
-Initial dose: 1000 lipase units/kg orally per meal
-Maintenance dose: Up to 2500 lipase units/kg orally per meal
-Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat ingested per day
4 years and older:
-Initial dose: 500 lipase units/kg orally per meal
-Maintenance dose: Up to 2500 lipase units/kg orally per meal
-Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat ingested per day
Usual Pediatric Dose for Cystic Fibrosis
Up to 12 months: 2000 to 4000 lipase units per 120 mL of formula or breastfeeding
Older than 12 months to younger than 4 years:
-Initial dose: 1000 lipase units/kg orally per meal
-Maintenance dose: Up to 2500 lipase units/kg orally per meal
-Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat ingested per day
4 years and older:
-Initial dose: 500 lipase units/kg orally per meal
-Maintenance dose: Up to 2500 lipase units/kg orally per meal
-Maximum dose: 10,000 lipase units/kg/day OR 4000 lipase units/gram fat ingested per day
Drug contraindications
Side effects
More common complications:
Blurred vision
Dry mouth
Wash skin, dry
The smell of fruity breath
Headache
Hunger has increased
Increased thirst
Increased urination
Sweating
Unexplained weight loss
Vomit
Less common complications:
Abnormal stools
Anxiety
Feeling bloated
لرز
Cold sweat
Confusion
Cool and pale skin
Depression
There is excess air or gas in the stomach or intestines
Feeling full
Fever
Frequent bowel movements
Loss of consciousness
Muscle aches
Nightmares
Gas passage
runny nose
Convulsions
To shake
Tongue tie
Sore throat
Rare side effects:
Skin rash or urticaria
Complications of high doses:
Ileus
Diarrhea
nausea
Stomach cramps or pain
Complications of very high doses:
Blood in the urine
joint's pain
Swelling of the legs or lower legs
Complications of powder form or powder from opened capsules:
- If a person suffers from nasal congestion while breathing, the chest feels tight
Side effects of holding the pill in the mouth:
Oral irritation
Side effects that are not known:
Cough
Difficulty swallowing
Vertigo
Fast heart rate
Itching
Noisy breathing
Swelling or swelling of the eyelids or around the eyes, face, lips and tongue
Redness of the skin
Severe stomach pain
Unusual fatigue or weakness
Interactions
Alerts
• Fibrosing colonopathy: Fibrosing colonopathy, advancing to colonic strictures, has been reported (rarely). Risk may be increased with high doses, prolonged use, and in pediatric patients with cystic fibrosis; however, the mechanism is unknown. Doses of lipase >6,000 units/kg/meal have been associated with colonic stricture in children <12 years. Patients taking doses of lipase >6,000 units/kg/meal should be examined and the dose decreased. Doses of lipase >2,500 units/kg/meal, lipase >10,000 units/kg/day, or lipase >4,000 units/g fat daily should be used with caution and only with documentation of effectiveness by 3-day fecal fat measures indicating a significantly improved coefficient of fat absorption.
• Hypersensitivity: Severe, allergic reactions (eg anaphylaxis, asthma, hives, pruritus) have rarely been observed; use with caution in patients hypersensitive to pork proteins, taking into consideration the patient's overall clinical needs.
• Mucosal irritation: Crushing or chewing the contents of the capsules or tablets, or mixing the capsule contents with foods outside of product labeling, may cause early release of the enzymes, causing irritation of the oral mucosa and/or loss of enzyme activity. When mixing the contents of capsules with food, the mixture should be swallowed immediately and followed with water or juice to ensure complete ingestion. Pancrelipase should not be mixed in foods with pH >4.5.
• Pork: Products are derived from porcine pancreatic glands. Transmission of porcine viruses, and diseases caused by novel or unidentified viruses, is theoretically a risk; however, testing and/or inactivation or removal of certain viruses, reduces the risk. There have been no cases of transmission of an infectious illness reported.
Ask a Pharmacist